Skip to main content

Closed

VVOS: Vivos Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+16.0% / yr

Operating margin-115.5%

ROIC-148.6%

Financially safe

Stretched

Debt / equity-10.78×

Interest coverage0.0×

Current ratio0.27×

Vivos Therapeutics, Inc.

VVOSNASDAQ·USD·Closed

Vivos Therapeutics, Inc.

VVOSNASDAQ·USD·Closed

$0.41

+1.01%

$0.41

+$0.00 (1.01%)

52W Range

1thpctl

Volume

0.11×avg

Mkt Cap

2.41MUSD

P/E

-0.2TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.11×avg

Market Cap

2.41MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings